← FDA Drug Approvals (Drugs@FDA)

OZANIMOD

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SYNTHON BV · Approved 2025-07-22

Drug application

FDA Application #

ANDA219236

Application type

Abbreviated New Drug Application (Generic)

Brand name

OZANIMOD

Generic name

Ozanimod

Active ingredients

OZANIMOD

Dosage form

CAPSULE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

SYNTHON BV

First approval

2025-07-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown